PROJECT

Projects

Summary of Investment Information

Project Number

45541

Company Name

DI'AN DIAGNOSTICS GROUP CO., LTD.

Date SPI Disclosed

Oct 11, 2021

Country

China

Region

East Asia and the Pacific

Projected Board Date

Nov 29, 2021

Environmental Category

B - Limited

Status

Active

Last Updated Date

Jun 11, 2022

Department

Regional Industry - MAS Asia & Pac

Industry

other

Previous Events

Approved : Jan 18, 2022
Signed : Jan 20, 2022
Invested : May 11, 2022

Sector

other

Project Description

The proposed investment will support Di’An Diagnostics Group Co., Ltd. (“Di’An”, “the Company” or “the Borrower”) to (i) expand and upgrade its existing ICL network and create 5 regional test centers through expansion of existing ICLs; (ii) add 5 “spoke” ICLs in second/third tier cities; (iii) build a manufacturing center for its self-developed In Vitro Diagnostic (“IVD”) products; (iv) fund R&D expenses to accelerate expansion in specialized testing and (v) build advanced IT infrastructure and data analytics function over the next five years (together, the “Project”). The additional testing capacity created by the Project will help to relieve capacity constraints at over-crowded public hospitals while expanding the types of testing available. 

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation